Incidence and mortality of cervical cancer in Latin America.

Cervical cancer incidence and mortality estimates for 2000 are presented for the 21 Latin American countries, using estimates from the statistical package GLOBOCAN 2000. Additional data on time-trends are also presented, using the WHO mortality database. By the year 2000, some 76,000 cervical cancer and almost 30,000 deaths were estimated for the whole region, which represent 16% and 13% of the world burden, respectively. Thus, Latin American countries are among those with highest incidence rates in the world, together with countries from Sub-Saharan Africa, South and South East Asia. Variation in incidence among countries is large. Very high rates are found in Haiti (ASR 93.9 per 100,000), Nicaragua (ASR 61.1 per 100,000) and Bolivia (ASR 58.1 per 100,000). It seems unlikely that differences in risks in the region can be explained as the result of screening activities. Several descriptive studies carried out to evaluate the screening programmes in Latin America have pointed out problems related to insufficient coverage and frequency of screening. Other related problems include inadequate collection and reading of cytological samplings as well as incomplete follow-up of women after the test. The main challenge for Latin America countries remains on how to organize effective screening programmes, and for this, a real and urgent commitment from public health services and decision-makers in the region is needed. This paper is available too at: http://www.insp.mx/salud/index.html.

[1]  V. Moreno,et al.  Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. , 1995, Journal of the National Cancer Institute.

[2]  N. Muñoz,et al.  Epidemiology of HPV infection among Mexican women with normal cervical cytology , 2001, International journal of cancer.

[3]  J. Ferlay,et al.  Estimates of cancer incidence and mortality in Europe in 1995. , 2002, European journal of cancer.

[4]  A. Polednak,et al.  Cancer in Haiti 1979–84: Distribution of various forms of cancer according to geographical area and sex , 1986, International journal of cancer.

[5]  A. Peruga,et al.  Trends in cervical cancer mortality in the Americas. , 1996, Bulletin of the Pan American Health Organization.

[6]  V. Moreno,et al.  Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study , 2002, The Lancet.

[7]  S. Franceschi,et al.  Prevalence and determinants of HPV infection among Colombian women with normal cytology , 2002, British Journal of Cancer.

[8]  L. Brinton,et al.  Screening for cervical cancer in Latin America: a case-control study. , 1992, International journal of epidemiology.

[9]  S. Wacholder,et al.  HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica , 2001, British Journal of Cancer.

[10]  N. Muñoz,et al.  HPV types and cofactors causing cervical cancer in Peru , 2001, British Journal of Cancer.

[11]  F. Bray,et al.  Cancer burden in the year 2000. The global picture. , 2001, European journal of cancer.

[12]  C. Albala,et al.  [Adult mortality from chronic diseases in Chile, 1968-1990]. , 1994, Notas de poblacion.

[13]  E. Saxén,et al.  Do the predictions for cancer incidence come true? experience from Finland , 1986, Cancer.

[14]  E. Franco,et al.  Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. , 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[15]  S. Hasan,et al.  Comparability and Quality Control in Cancer Registration; Karachi (data monitoring 1995-2001). , 2002, JPMA. The Journal of the Pakistan Medical Association.

[16]  M. Plummer,et al.  Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. , 2000, Journal of the National Cancer Institute.

[17]  E. Saxén,et al.  Risk indicators of breast and cervical cancer on ecologic and individual levels. , 1982, American journal of epidemiology.

[18]  V. Moreno,et al.  Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study , 2002, The Lancet.

[19]  J. Ferlay,et al.  Globocan 2000 : cancer incidence, mortality and prevalence worldwide , 2001 .

[20]  M. Jiménez-Pérez,et al.  Has the use of pap smears reduced the risk of invasive cervical cancer in Guadalajara, Mexico? , 1999, International journal of cancer.

[21]  J. Ferlay,et al.  Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.

[22]  R. Lozano,et al.  [The epidemiological transition in Latin America]. , 1994, Notas de poblacion.

[23]  T. Romero,et al.  Evaluation of the cervical cancer control program in Cuba. , 1996, Bulletin of the Pan American Health Organization.

[24]  Jacques Ferlay,et al.  Estimates of the worldwide incidence of 25 major cancers in 1990 , 1999, International journal of cancer.

[25]  Day Ne The epidemiological basis for evaluating different screening policies. , 1986 .

[26]  Julian Peto,et al.  Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective , 1995 .

[27]  L. López-Carrillo,et al.  Validity and reproducibility of cytologic diagnosis in a sample of cervical cancer screening centers in Mexico. , 1997, Acta cytologica.

[28]  P. Correa,et al.  The impact of vaginal cytology on cervical cancer risks in cali, Colombia , 1984, International journal of cancer.

[29]  R. Rajkumar,et al.  Effective screening programmes for cervical cancer in low- and middle-income developing countries. , 2001, Bulletin of the World Health Organization.

[30]  A. Lopez,et al.  Global and regional mortality patterns by cause of death in 1980. , 1986, International journal of epidemiology.

[31]  P. A. de Ruíz,et al.  Evaluation of the cervical cancer screening programme in Mexico: a population-based case-control study. , 1998, International journal of epidemiology.

[32]  H. Cronje,et al.  Screening for cervical cancer in developing countries , 2004, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[33]  K. Holmes,et al.  Determinants of cervical cancer rates in developing countries , 2002, International journal of cancer.